Bio Medica Laboratories Key Ratios
NSE: BMLL
₹162.30
₹1.40
(0.87%)
As on 03-Sep-2026 15:31IST
Market cap
₹202 Cr
Revenue (TTM)
₹38 Cr
P/E Ratio
16.9
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 150.47 | -- | -- |
| EBIT | -- | -- | 217.76 | -- | -- |
| Net Profit | -- | -- | 292.00 | -- | -- |
| EPS | -- | -- | 292.00 | -- | -- |
| Book Value | -- | -- | 198.35 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 37.62 | 29.65 | 7.41 |
| Net Margin
| -- | -- | 25.56 | 16.28 | 2.05 |
| Return on equity
| -- | -- | 99.59 | 67.74 | 13.67 |
| Return on Capital
| -- | -- | 64.18 | 33.61 | 10.17 |
| Return on Assets
| -- | -- | 33.60 | 13.53 | 1.90 |
| Debt to Equity (x)
| -- | -- | 1.02 | 2.12 | 3.94 |
Profitability
ROCE
64.18
Higher than Peers by 60.35
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
64.18
|
33.61
|
10.17
|
--
|
--
|
|
Peer Median
|
3.84
|
5.02
|
9.20
|
11.47
|
--
|
ROE
99.59
Higher than Peers by 94.51
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
99.59
|
67.74
|
13.67
|
--
|
--
|
|
Peer Median
|
5.08
|
1.59
|
9.09
|
3.59
|
--
|
ROA
33.60
Higher than Peers by 31.41
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
33.60
|
13.53
|
1.90
|
--
|
--
|
|
Peer Median
|
2.19
|
1.46
|
2.77
|
1.32
|
--
|
EBIT Margin
37.62
Higher than Peers by 34.68
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
37.62
|
29.65
|
7.41
|
--
|
--
|
|
Peer Median
|
2.93
|
3.78
|
4.14
|
-0.17
|
--
|
Net Margin
25.56
Higher than Peers by 23.60
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
25.56
|
16.28
|
2.05
|
--
|
--
|
|
Peer Median
|
1.96
|
3.27
|
13.99
|
1.55
|
--
|
Cash Profit Margin
28.28
Higher than Peers by 28.28
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
28.28
|
23.66
|
5.12
|
--
|
--
|
|
Peer Median
|
0.00
|
0.00
|
0.00
|
0.00
|
--
|
Revenue Growth
150.47
Higher than Peers by 99.72
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
150.47
|
-6.03
|
--
|
--
|
--
|
|
Peer Median
|
50.75
|
56.32
|
1,43,500.00
|
12.18
|
--
|
EBIT Growth
217.76
Higher than Peers by 142.71
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
217.76
|
275.79
|
--
|
--
|
--
|
|
Peer Median
|
75.04
|
59.55
|
-70.24
|
11.56
|
--
|
Net Profit Growth
292.00
Higher than Peers by 252.04
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
292.00
|
649.24
|
--
|
--
|
--
|
|
Peer Median
|
39.96
|
-8.68
|
-48.33
|
-3.70
|
--
|
EPS Growth
292.00
Higher than Peers by 313.00
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
292.00
|
649.22
|
--
|
--
|
--
|
|
Peer Median
|
-21.00
|
--
|
--
|
-3.70
|
--
|
Book Value Growth
198.35
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
198.35
|
102.42
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.02
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
1.02
|
2.12
|
3.94
|
--
|
--
|
|
Peer Median
|
--
|
0.63
|
--
|
--
|
--
|
Short term debt to equity ratio
0.43
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
0.43
|
0.35
|
1.53
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.83
Lower than Peers by 0.64
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
1.83
|
1.61
|
0.89
|
--
|
--
|
|
Peer Median
|
2.47
|
2.33
|
5.05
|
5.68
|
--
|
Quick Ratio
0.76
Lower than Peers by 0.91
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
0.76
|
0.49
|
0.51
|
--
|
--
|
|
Peer Median
|
1.68
|
10.32
|
6.03
|
5.55
|
--
|
Interest Coverage
10.70
Higher than Peers by 8.04
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
10.70
|
4.78
|
1.59
|
--
|
--
|
|
Peer Median
|
2.66
|
2.65
|
2.05
|
5.69
|
--
|
Operating Efficiency
Debtors to sales
10.73
Lower than Peers by 4.63
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
10.73
|
15.32
|
25.10
|
--
|
--
|
|
Peer Median
|
15.37
|
42.99
|
49.21
|
11.90
|
--
|
Asset Turnover
1.31
Lower than Peers by 0.20
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
1.31
|
0.83
|
0.93
|
--
|
--
|
|
Peer Median
|
1.51
|
1.33
|
0.50
|
1.10
|
--
|
Receivable days
30.75
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
30.75
|
76.70
|
91.61
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
121.86
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
121.86
|
134.86
|
87.76
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
117.74
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
117.74
|
361.42
|
360.74
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
34.88
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
34.88
|
-149.86
|
-181.37
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
65.30
|
159.13
|
107.97
|
115.95
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.35
|
3.26
|
2.54
|
2.60
|
--
|
EV/EBITDA
1.56
Lower than Peers by 51.79
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
1.56
|
1.85
|
5.64
|
--
|
--
|
|
Peer Median
|
53.35
|
29.43
|
2.43
|
179.61
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Bio Medica Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
30
|
20
|
13
|
13
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
